The ATXR4 Antibody is a research tool designed to detect Histone lysine N-methyltransferase ATXR4 (Gene: ATXR4), also known as SET domain protein 38 (SDG38) in Arabidopsis thaliana. This antibody targets a key enzyme involved in histone methylation, a post-translational modification critical for regulating gene expression and chromatin structure . ATXR4 belongs to the SET domain-containing protein family, which catalyzes the transfer of methyl groups to lysine residues on histone proteins, influencing epigenetic regulation .
Gene Locus: AT5G06620 (Chromosome 5, Arabidopsis thaliana) .
Protein Domains: Contains a conserved SET domain, responsible for methyltransferase activity .
Molecular Weight: ~70–85 kDa (predicted based on sequence homology with related methyltransferases) .
ATXR4 regulates histone H3 lysine methylation, impacting:
The ATXR4 Antibody is widely used in plant epigenetics and developmental biology studies. Key applications include:
Western Blot: Detects a single band at ~80 kDa in Arabidopsis stem extracts .
Immunofluorescence: Nuclear localization in shoot apical meristems .
ATXR4 indirectly regulates genes like CER3 and WSD1, which are critical for cuticular wax deposition in Arabidopsis stems .
Mechanism: Modifies histone acetylation at wax biosynthesis gene loci .
Co-immunoprecipitation studies link ATXR4 to GCN5, a histone acetyltransferase, suggesting a balance between acetylation and methylation marks .
ATF4 antibodies are primarily used for detecting and studying the ATF4 transcription factor in various experimental contexts. Common applications include Western blot analysis, where specific bands can be detected at approximately 47 kDa, and immunocytochemistry for visualizing ATF4 localization in both nuclear and cytoplasmic compartments . For plant research, antibodies targeting ATX4 (ARABIDOPSIS TRITHORAX4) are valuable for studying chromatin modification mechanisms related to transcriptional activation, particularly in drought stress responses .
When designing experiments, researchers should consider:
Tissue/cell type specificity (ATF4 expression varies across cell types)
Appropriate positive controls (such as Jurkat human acute T cell leukemia cell lines for human ATF4)
Selection of complementary detection methods to validate findings
For optimal Western blot detection of ATF4, researchers should:
Use PVDF membranes for protein transfer
Apply approximately 2 μg/mL of the primary antibody (when using Mouse Anti-Human ATF4 Antibody)
Conduct experiments under reducing conditions
Employ appropriate buffer systems (e.g., Immunoblot Buffer Group 1 for human ATF4)
For plant ATX4 detection, protocols must be adapted to plant tissue preparation methods, with special consideration for nuclear protein extraction efficiency due to ATX4's role in chromatin modification.
To maintain optimal antibody activity:
Store unopened antibodies at -20 to -70°C for up to 12 months from receipt
After reconstitution, store at 2-8°C for up to 1 month under sterile conditions
For longer-term storage (up to 6 months), keep at -20 to -70°C under sterile conditions after reconstitution
Use a manual defrost freezer and avoid repeated freeze-thaw cycles that can compromise antibody performance
Validating antibody specificity requires multiple approaches:
Positive and negative controls: Use known positive samples (e.g., Jurkat cells for human ATF4) and appropriate negative controls (such as knockdown/knockout cell lines)
Blocking peptide experiments: Pre-incubate the antibody with its target peptide sequence to demonstrate specific binding
Cross-reactivity assessment: Test the antibody against related proteins to ensure specificity (particularly important for distinguishing between ATF4 and other bZIP family members)
Multiple detection methods: Compare results across techniques like Western blot, immunofluorescence, and chromatin immunoprecipitation
Antibody validation databases: Cross-reference antibody performance with published validation data
Researchers working with chromatin-associated proteins like ATX4 frequently encounter several challenges:
Extraction efficiency: Nuclear proteins often require specialized extraction protocols to ensure complete recovery from chromatin
Cross-linking variables: For ChIP applications, optimization of formaldehyde cross-linking time and concentration is critical for capturing transient chromatin interactions
Background signal: High background can occur due to the nuclear localization and relatively low abundance of ATX4
Epitope accessibility: Protein-DNA interactions may mask antibody epitopes, requiring careful optimization of immunoprecipitation conditions
Dynamic binding patterns: ATX4 occupancy at target loci (like AHG3) changes significantly under different conditions (e.g., ABA treatment), necessitating careful experimental timing
Based on current research findings, experimental design should incorporate:
Phenotypic analysis: Compare wild-type, single mutants (atx4 and atx5), and double mutants (atx4 atx5) under controlled drought conditions to assess stress tolerance phenotypes
ABA sensitivity assays: Measure seed germination and seedling development rates under varying ABA concentrations (particularly important as mutants show hypersensitive phenotypes)
Gene expression profiling: Implement genome-wide RNA-sequencing to identify ATX4/ATX5-regulated genes involved in dehydration stress responses
ChIP assays: Assess ATX4/ATX5 occupancy at target loci (particularly AHG3) and quantify H3K4 trimethylation levels with and without ABA treatment
RNA polymerase II occupancy: Measure RNAPII recruitment to validate the impact of ATX4/ATX5 on transcriptional activation
For successful ChIP experiments targeting ATX4/ATF4:
Crosslinking optimization: For plant chromatin, typical conditions include 1% formaldehyde for 10-15 minutes, but this should be optimized for specific tissue types
Sonication parameters: Adjust sonication conditions to achieve chromatin fragments of 200-500 bp for optimal immunoprecipitation
Antibody selection: Choose ChIP-validated antibodies with demonstrated ability to recognize the native protein in its chromatin-bound state
Controls: Include input controls, IgG controls, and positive controls (known binding regions like AHG3 for ATX4)
Signal quantification: Use qPCR to measure enrichment at specific loci, considering that ATX4 occupancy increases significantly under stress conditions (e.g., ABA treatment)
Sequential ChIP: For studying co-occupancy with other factors, sequential ChIP may be necessary to confirm simultaneous binding
Computational approaches provide powerful tools for antibody research:
Epitope prediction: Algorithms can identify potential immunogenic regions in target proteins to guide antibody development
Binding mode identification: Computational models can distinguish different binding modes associated with particular ligands, allowing for more nuanced understanding of antibody-antigen interactions
Cross-reactivity prediction: Machine learning approaches can predict potential cross-reactivity with similar proteins, helping researchers select antibodies with optimal specificity
Custom specificity design: As demonstrated with other antibodies, computational methods enable the design of antibodies with customized specificity profiles, either highly specific for a single target or cross-specific for multiple related targets
Selection bias mitigation: Computational approaches can help identify and correct for experimental artifacts and biases in selection experiments
ATX4 and ATX5 show functional overlap but also distinct roles:
Genetic analysis: Compare single mutants (atx4 or atx5) with double mutants (atx4 atx5) to distinguish shared versus unique functions
ChIP-seq profiling: Generate genome-wide binding profiles for both proteins under identical conditions to identify unique and shared target loci
Sequential ChIP: Use sequential immunoprecipitation to determine co-occupancy at specific genomic regions
Protein-protein interaction studies: Employ co-immunoprecipitation, yeast two-hybrid, or proximity labeling approaches to identify specific interacting partners for each protein
Histone modification analysis: Quantify changes in H3K4 trimethylation patterns in single versus double mutants to assess individual contributions to this epigenetic mark
Temporal regulation analysis: Investigate the timing of ATX4 versus ATX5 recruitment to target loci during stress responses
When facing contradictory results:
Antibody validation: Confirm antibody specificity using multiple approaches including Western blot, immunoprecipitation, and immunofluorescence with appropriate controls
Experimental conditions: Evaluate how differences in sample preparation, buffer composition, or detection methods might influence outcomes
Protein isoforms: Consider the possibility of detecting different ATF4 isoforms, as the protein can undergo post-translational modifications that affect antibody recognition
Cellular context: Assess whether contradictions stem from different cell types or physiological states, as ATF4 expression and localization change under stress conditions
Technical replicates: Increase the number of technical and biological replicates to strengthen statistical analysis
Alternative antibodies: Test multiple antibodies targeting different epitopes to validate findings
Common technical issues and solutions include:
Weak signal:
Optimize antibody concentration (try 10 μg/mL as a starting point for ATF4)
Extend incubation time (3+ hours at room temperature or overnight at 4°C)
Enhance antigen retrieval methods for fixed samples
Use signal amplification systems
High background:
Increase blocking time and concentration
Optimize washing steps (more frequent, longer washes)
Pre-absorb secondary antibodies
Use appropriate negative controls to distinguish true signal from background
Inconsistent localization:
Consider that ATF4 can localize to both nucleus and cytoplasm depending on cellular conditions
Control fixation conditions to prevent artifactual redistribution
Compare multiple fixation methods (paraformaldehyde vs. methanol)
Poor reproducibility:
For rigorous quantitative analysis:
Loading controls: Use appropriate housekeeping proteins as loading controls (β-actin, GAPDH, or histone H3 for nuclear proteins)
Dynamic range verification: Perform dilution series to confirm signal linearity within the working range
Normalization approach: Apply consistent normalization methods across experiments:
Normalize ATF4 signal to loading control
Use internal reference samples across multiple blots
Replication requirements: Perform at least three biological replicates for statistical validity
Image acquisition: Use a calibrated imaging system with linear dynamic range
Quantification software: Employ specialized software (ImageJ, Image Lab) for densitometric analysis
Statistical analysis: Apply appropriate statistical tests for comparing expression levels across conditions
Integrating antibodies into single-cell workflows requires specialized approaches:
Single-cell Western blot: Adapt protocols for microfluidic single-cell Western blotting platforms, optimizing antibody concentrations for smaller sample volumes
Mass cytometry (CyTOF): Conjugate ATF4 antibodies with rare earth metals for high-dimensional single-cell protein analysis
scRNA-seq validation: Use immunofluorescence with ATF4 antibodies to validate protein-level expression in subpopulations identified by single-cell transcriptomics
Proximity ligation assays: Combine ATF4 antibodies with antibodies against interaction partners to visualize protein complexes at the single-cell level
CITE-seq approach: Consider developing oligo-tagged ATF4 antibodies for simultaneous protein and RNA detection in single cells
Studying temporal dynamics requires specialized techniques:
Time-course ChIP experiments: Perform ChIP at multiple timepoints after stress induction (e.g., ABA treatment) to track changes in ATX4 occupancy
Live-cell imaging: Develop fluorescently tagged ATX4 constructs for real-time visualization of protein recruitment to chromatin in living cells
Degradation tagging systems: Use auxin-inducible or other rapid protein degradation systems to study the immediate consequences of ATX4 removal
Nascent RNA sequencing: Combine with ATX4 ChIP data to correlate binding events with transcriptional outcomes over time
Sequential ChIP time-course: Track the temporal order of recruitment of different chromatin modifiers (e.g., ATX4 followed by RNA Polymerase II)
Epigenomic profiling: Monitor changes in H3K4 trimethylation patterns over time in response to ATX4 binding
Advanced computational approaches offer several benefits:
Epitope optimization: Computational analysis can identify unique epitopes with minimal similarity to related proteins, reducing cross-reactivity
Custom specificity profiles: Design antibodies with predetermined binding profiles:
Highly specific antibodies that recognize only ATX4 but not the closely related ATX5
Cross-specific antibodies that can recognize conserved regions across multiple species
Structure-guided design: Use protein structure predictions to target conformational epitopes unique to ATX4/ATF4
Phage display optimization: Computational analysis of phage display results can identify sequence patterns associated with desired binding properties
Machine learning approaches: Apply machine learning to predict antibody-antigen interactions and optimize binding characteristics
Epitope accessibility analysis: Computational methods can predict which regions of the target protein are likely to be accessible in different experimental contexts
For robust ChIP-seq analysis of histone modifiers:
Peak calling algorithms: Use specialized algorithms like MACS2 or SICER that accommodate the broader peak profiles typical of histone modifications
Input normalization: Properly normalize to input controls to account for biases in chromatin accessibility and sonication efficiency
Differential binding analysis: Apply tools like DiffBind or MAnorm to identify statistically significant differences in ATX4 occupancy between conditions
Integration with transcriptome data: Correlate ATX4 binding patterns with gene expression changes to identify functional binding events
Motif analysis: Identify DNA sequence motifs enriched in ATX4-bound regions to understand binding preferences
Gene set enrichment analysis: Determine whether ATX4-bound genes are enriched for specific functional categories or pathways
False discovery rate control: Apply multiple testing correction (Benjamini-Hochberg) to control false discovery rates in genome-wide analyses
Comprehensive validation requires integrating multiple approaches:
Genetic knockout validation: Compare antibody staining patterns in wild-type versus knockout/knockdown backgrounds to confirm specificity
Rescue experiments: Reintroduce wild-type or mutant versions of ATX4/ATF4 into knockout backgrounds to validate function and antibody recognition
Domain-specific mutations: Create targeted mutations in functional domains (e.g., the H3K4 methyltransferase domain of ATX4) to correlate with antibody-detected changes in activity
ChIP-seq and RNA-seq integration: Combine ChIP-seq identification of ATX4 binding sites with RNA-seq of knockout lines to connect binding with function
Allele-specific antibodies: Develop antibodies that specifically recognize wild-type or mutant versions of the protein
Inducible expression systems: Use temporally controlled expression to study acute versus chronic effects of ATX4/ATF4 function
To discriminate between direct and indirect effects:
Direct binding evidence: Use ChIP or CUT&RUN to demonstrate physical association of ATX4 with target gene loci
Temporally resolved experiments: Perform time-course studies to identify primary (early) versus secondary (late) transcriptional responses
Inducible rapid degradation: Employ systems for rapid protein depletion (e.g., auxin-inducible degron) combined with transcriptional profiling to identify immediate targets
Transcriptional inhibition: Use transcriptional inhibitors to block secondary effects mediated by ATX4-regulated transcription factors
H3K4me3 correlation: Demonstrate correlation between ATX4 binding, changes in H3K4 trimethylation, and gene expression
Biochemical reconstitution: In vitro transcription assays with purified components to demonstrate direct effects on transcriptional machinery